Tradestie Institutional Equity Comparison Engine

AAUS vs RADX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

RADX Overall Edge

RADX Captures Institutional Edge (1โ€“1 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Radiopharm Theranostics Limited American Depositary Shares (RADX) driven by superior Growth & Margin while AAUS counters with relative strength in Momentum & Technical. Fundamentally, AAUS trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus RADX at N/M Forward P/E and -411.6% operating margin (-36.9% YoY). In options structure, AAUS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against RADX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
AAUS N/M vs RADX N/M Fwd P/E
Growth & Margin Winner RADX
Op Margin N/A vs -411.6% ยท YoY N/A vs -36.9%
Momentum & Technical Winner AAUS
1Y +1.5% vs -86.0% ยท 52W Pos 32% vs 0%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
AAUS US Equity
AAUS
Institutional Equity
$55.08
-3.9% 1D
Market Cap N/A
1M Return -10.24%
1Y Return +1.53%
Forward P/E N/M
Unified AI Score
43.4 / 100 HOLD
Tech 28.0 Fund 48.0 Flow 50.0 Mom 55.0
RADX NASDAQ
Radiopharm Theranostics Limited American Depositary Shares
Pharmaceutical Preparations
$0.63
-6.33% 1D
Market Cap $10.6M
1M Return -33.64%
1Y Return -86.04%
Forward P/E N/M
Unified AI Score
41.1 / 100 SELL
Tech 25.0 Fund 45.0 Flow 50.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AAUS +1.53% RADX -86.04% Spread: +88.19 pp (AAUS Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
AAUS TTM Op. Margin: N/A RADX TTM Op. Margin: -411.6%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AAUS vs RADX. Trailing 12-month operating profitability (AAUS N/A vs RADX -411.6%) and valuation multiples (AAUS N/M vs RADX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AAUS (3) vs RADX (5)
Institutional Metric AAUS RADX Criterion Row Winner
Market Capitalization Scale N/A $10.6M Larger Scale RADX
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A -36.9% Higher Growth RADX
Operating Margin (TTM) Profitability N/A -411.6% Higher Margin RADX
Net Profit Margin Profitability N/A 0.0% Higher Margin RADX
Return on Equity (ROE) Capital Efficiency N/A -174.7% Higher ROE RADX
52-Week Range Position Momentum 32% ($51โ€“$64) 0% ($1โ€“$16) Stronger Trend AAUS
Beta / 30D Volatility Risk Regime 0.97ฮฒ ยท 24% Vol 0.52ฮฒ ยท 109% Vol Lower Realized Risk AAUS
Unified Institutional Score Composite Signal 43.4 / 100 (HOLD) 41.1 / 100 (SELL) Higher Composite AAUS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AAUS vs RADX Buy Guide
AAUS UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live AAUS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
RADX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live RADX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AAUS nor RADX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.